在糖尿病病中,IGFBP2和IGFBP4相互作用激活补充通路
Jieling Liang1,2, Yangxiao Huang2, Daping Peng2
1Guangdong Medical University, Dongguan, China.
Renal failure
|January 14, 2025
概括
胰岛素样生长因子结合蛋白2 (IGFBP2) 和4 (IGFBP4) 激活了巨细胞中的补体通路,导致细胞亡和糖尿病病 (DKD) 的进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病病 (DKD) 是全球慢性病的主要原因.
- 胰岛素样生长因子结合蛋白2 (IGFBP2) 和4 (IGFBP4) 正成为潜在的DKD生物标志物.
- 补充通路过度激活在DKD病变发生过程中的作用尚未完全理解.
研究的目的:
- 研究IGFBP2,IGFBP4和补充激活在DKD中的作用.
- 阐明将这些因素与DKD发展联系起来的分子机制.
主要方法:
- 来自DKD患者的血液样本的蛋白质组分析.
- 使用HK-2和THP-1细胞系进行体外研究.
- 在DKD小鼠模型中的体内实验.
- 对人类初级脏细胞反应的研究.
主要成果:
- 在DKD患者和小鼠中发现IGFBP2和IGFBP4水平升高.
- 在DKD小鼠中,IGFBP2/IGFBP4增加,补充激活,功能恶化.
- 高葡萄糖和DKD血清增加了HK-2细胞中的IGFBP2/IGFBP4,促进了M1巨分极和补体激活.
- 巨衍生因素,而不是单独的IGFBP2/IGFBP4,损害了细胞的生长.
结论:
- IGFBP2和IGFBP4相互作用,激活巨细胞中的补体通路.
- 这种巨细胞介导的补充激活会诱导 podocyte 亡.
- IGFBP2/IGFBP4巨补充轴是糖尿病病进展的关键驱动因素.
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
165
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
165
01:28Insulin: The Receptor and Signaling Pathways
1.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.1K
01:05Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
01:22Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K